18-68837062-C-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_024781.3(CCDC102B):c.299C>T(p.Ala100Val) variant causes a missense change. The variant allele was found at a frequency of 0.00000929 in 1,613,922 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000020 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000082 ( 1 hom. )
Consequence
CCDC102B
NM_024781.3 missense
NM_024781.3 missense
Scores
5
10
4
Clinical Significance
Conservation
PhyloP100: 5.70
Genes affected
CCDC102B (HGNC:26295): (coiled-coil domain containing 102B)
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCDC102B | NM_024781.3 | c.299C>T | p.Ala100Val | missense_variant | 2/8 | ENST00000360242.9 | NP_079057.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCDC102B | ENST00000360242.9 | c.299C>T | p.Ala100Val | missense_variant | 2/8 | 1 | NM_024781.3 | ENSP00000353377.5 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152056Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
3
AN:
152056
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000401 AC: 1AN: 249134Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135134
GnomAD3 exomes
AF:
AC:
1
AN:
249134
Hom.:
AF XY:
AC XY:
0
AN XY:
135134
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000821 AC: 12AN: 1461866Hom.: 1 Cov.: 75 AF XY: 0.00000275 AC XY: 2AN XY: 727230
GnomAD4 exome
AF:
AC:
12
AN:
1461866
Hom.:
Cov.:
75
AF XY:
AC XY:
2
AN XY:
727230
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152056Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74260
GnomAD4 genome
AF:
AC:
3
AN:
152056
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
74260
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 19, 2024 | The c.299C>T (p.A100V) alteration is located in exon 4 (coding exon 1) of the CCDC102B gene. This alteration results from a C to T substitution at nucleotide position 299, causing the alanine (A) at amino acid position 100 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
.;.;T;.;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Pathogenic
D;D;D;D;D
M_CAP
Benign
D
MetaRNN
Uncertain
D;D;D;D;D
MetaSVM
Benign
T
MutationAssessor
Uncertain
.;.;M;.;M
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
.;.;D;.;.
REVEL
Uncertain
Sift
Pathogenic
.;.;D;.;.
Sift4G
Uncertain
D;D;D;D;D
Polyphen
1.0
.;.;D;.;.
Vest4
0.91, 0.78
MutPred
Gain of catalytic residue at A100 (P = 0.0473);Gain of catalytic residue at A100 (P = 0.0473);Gain of catalytic residue at A100 (P = 0.0473);Gain of catalytic residue at A100 (P = 0.0473);Gain of catalytic residue at A100 (P = 0.0473);
MVP
MPC
0.095
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at